FLS
71
2
CI
66
-3
TMO
67
3
F
56
-2
TGT
63
-2
CME
52
-7
ALLE
53
-2
CAT
72
2
SE
49
-3
CHK
27
-7
AES
69
-10
PCG
96
11
CSCO
60
3
MMM
35
3
CL
69
2
MCD
52
6
MKC
47
2
JNPR
46
3
BDX
59
10
BRK.B
49
4
FLS
71
2
CI
66
-3
TMO
67
3
F
56
-2
TGT
63
-2
CME
52
-7
ALLE
53
-2
CAT
72
2
SE
49
-3
CHK
27
-7
AES
69
-10
PCG
96
11
CSCO
60
3
MMM
35
3
CL
69
2
MCD
52
6
MKC
47
2
JNPR
46
3
BDX
59
10
BRK.B
49
4
Financhill
Back

Akero Therapeutics Vs. Kinsale Capital Group Industry Stock Comparison

Sell
34

AKRO
Akero Therapeutics

Last Price:
19.65
Seasonality Move:
17.5%
Sell
48

KNSL
Kinsale Capital Group

Last Price:
380.70
Seasonality Move:
22.12%
Sell
34
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $19.65. The Score for AKRO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Kinsale Capital Group (KNSL) is a Sell

Is Kinsale Capital Group a Buy, Sell or Hold?

  • The current Kinsale Capital Group [KNSL] share price is $380.65. The Score for KNSL is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • KNSL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $19.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

KNSL Stock Price Chart

What is Kinsale Capital Group's stock price today?

  • The Kinsale Capital Group share price today is $380.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSL is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.69 Sell
Relative Strength Index (14 RSI): 39.39 Sell
Chaikin Money Flow: -530509 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.8 - 22.16) Sell
Bollinger Bands (100): (20.24 - 26.04) Sell

KNSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -23.79 Sell
Relative Strength Index (14 RSI): 33.94 Sell
Chaikin Money Flow: -115543 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (382.79 - 459.07) Sell
Bollinger Bands (100): (370.23 - 498.33) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.63 Sell
20-day SMA: 20.59 Sell
50-day SMA: 23.81 Sell
200-day SMA: 27.64 Sell
8-day EMA: 20.57 Sell
20-day EMA: 20.99 Sell
50-day EMA: 22.23 Sell
200-day EMA: 26.78 Sell

KNSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 384.04 Sell
20-day SMA: 413.11 Sell
50-day SMA: 465.69 Sell
200-day SMA: 409.33 Sell
8-day EMA: 387.51 Sell
20-day EMA: 408.77 Sell
50-day EMA: 435.46 Sell
200-day EMA: 409.01 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.91 per share, and a decrease next year of $0.58 per share.

Kinsale Capital Group Earnings Growth & KNSL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.78 per share, an increase next quarter of $0.67 per share, an increase this year of $2.79 per share, and an increase next year of $2.61 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kinsale Capital Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):